Lindbrook Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$2.56M Buy
12,237
+848
+7% +$178K 0.24% 65
2024
Q4
$2.02M Sell
11,389
-110
-1% -$19.5K 0.18% 75
2024
Q3
$2.27M Buy
11,499
+265
+2% +$52.3K 0.2% 71
2024
Q2
$1.93M Buy
11,234
+751
+7% +$129K 0.18% 81
2024
Q1
$1.91M Buy
10,483
+689
+7% +$125K 0.18% 80
2023
Q4
$1.52M Buy
9,794
+591
+6% +$91.6K 0.15% 88
2023
Q3
$1.37M Buy
9,203
+629
+7% +$93.8K 0.15% 90
2023
Q2
$1.16M Sell
8,574
-1,781
-17% -$240K 0.12% 105
2023
Q1
$1.65M Sell
10,355
-253
-2% -$40.3K 0.19% 77
2022
Q4
$1.71M Buy
10,608
+944
+10% +$153K 0.21% 77
2022
Q3
$1.3M Buy
9,664
+1,239
+15% +$166K 0.22% 60
2022
Q2
$1.29M Buy
8,425
+163
+2% +$25K 0.21% 61
2022
Q1
$1.34M Sell
8,262
-295
-3% -$47.8K 0.21% 68
2021
Q4
$1.16M Buy
8,557
+4,077
+91% +$552K 0.18% 71
2021
Q3
$483K Hold
4,480
0.13% 72
2021
Q2
$505K Sell
4,480
-904
-17% -$102K 0.11% 76
2021
Q1
$583K Buy
5,384
+114
+2% +$12.3K 0.13% 60
2020
Q4
$565K Buy
5,270
+653
+14% +$70K 0.14% 57
2020
Q3
$404K Sell
4,617
-39
-0.8% -$3.41K 0.11% 75
2020
Q2
$457K Buy
4,656
+429
+10% +$42.1K 0.14% 56
2020
Q1
$322K Sell
4,227
-673
-14% -$51.3K 0.12% 71
2019
Q4
$434K Buy
4,900
+153
+3% +$13.6K 0.15% 69
2019
Q3
$359K Buy
4,747
+214
+5% +$16.2K 0.14% 74
2019
Q2
$329K Sell
4,533
-312
-6% -$22.6K 0.13% 81
2019
Q1
$390K Buy
4,845
+965
+25% +$77.7K 0.16% 66
2018
Q4
$357K Buy
+3,880
New +$357K 0.18% 61